Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
International Journal of Infectious Diseases
International Society for Infectious Diseases
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Supplements
  • Collections
    • Back
    • World TB Day 2021
    • IJID COVID-19
    • Emerging Infectious Diseases in the Time of Ebola
    • Featured Content
  • For Authors
    • Back
    • About Open Access
    • Author Information
    • Permissions
    • Researcher Academy 
    • Submit a Manuscript 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact Information
    • Editorial Board
    • Info for Advertisers 
    • Reprints 
    • New Content Alerts
  • News and Media
  • ISID 
  • ProMED 
  • More Periodicals
    • Back
    • Find a Periodical 
    • Go to Product Catalog 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Claim
x

Filter:

Filters applied

  • Coronavirus (COVID-19) Collection
  • Contact tracingRemove Contact tracing filter
  • 2017 - 2022Remove 2017 - 2022 filter
Clear all

Article Type

  • Research Article5
  • Case Reports1
  • Rapid Communication1
  • Review Article1

Author

  • Maathuis, Marloes H2
  • Mettler, Sofia K2
  • Alaya, Nissaf Ben1
  • Arfaoui, Latifa1
  • Au, Ka Wing Albert1
  • Bouguerra, Hend1
  • Chan, Yung Wai Desmond1
  • Cheng, Hao-Yuan1
  • Cho, Jinwoo1
  • Choi, Yoon-Jung1
  • Chuang, Shuk Kwan1
  • Connor, John H1
  • Hamer, Davidson H1
  • Hchaichi, Aicha1
  • Ho, Po-Han1
  • Hong, Dongui1
  • Hong, Yun-Chul1
  • Hsairi, Mohamed1
  • Huang, Xiang-Ting1
  • Jang, Yoonyoung1
  • Jian, Shu-Wan1
  • Kim, Jihoo1
  • Lam, Chau Kuen Yonnie1
  • Lam, Ho Yeung1
  • Lam, Tsz Sum1

Journal

  • International Journal of Infectious Diseases9

Keyword

  • COVID-198
  • Diagnostic serial interval2
  • SARS-CoV-22
  • Serial interval2
  • Agent based model1
  • Clinical onset serial interval1
  • Cluster1
  • Coronavirus1
  • Delta variant1
  • Design1
  • Digital tool1
  • Enhanced surveillance1
  • Epidemic control1
  • Epidemics1
  • General lockdown1
  • Health inequities1
  • Hong Kong1
  • Inapparent infection1
  • Isolation1
  • Mathematical model1
  • Modelling1
  • Novel coronavirus1
  • Outbreak response1
  • PCR testing1

Access Filter

  • Open Access

Coronavirus (COVID-19) Collection

9 Results
Subscribe to collection
  • Export
    • PDF
    • Citation

Please select at least one article in order to proceed.

Ok
FilterHide Filter
  • Case Reports
    Open Access

    Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster

    International Journal of Infectious Diseases
    Vol. 114p62–64Published online: October 29, 2021
    • Hannah E. Landsberg
    • Jacquelyn Turcinovic
    • Madison Sullivan
    • John H. Connor
    • Davidson H. Hamer
    • Judy T. Platt
    Cited in Scopus: 1
    • Preview Hide Preview
    • Download PDF
    • Export Citation
      With the world in a race to vaccinate as many people as possible, concerns about vaccine efficacy have continued to arise, particularly related to variants of concern (VoC). The latest variant to be upgraded to a VoC was first discovered in India: B.1.617. This variant has three different subtypes including Delta or B.1.617.2, which has become the most reported lineage in India and has been responsible for a devastating second wave of infection in the country (Outbreak.info, 2021). This variant is defined by seven mutations in the spike protein, two of which – L452R and T478K – are suspected to increase transmissibility (Adam, 2021).
      Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster
    • Research Article
      Open Access

      The importance of timely contact tracing — A simulation study

      International Journal of Infectious Diseases
      Vol. 108p309–319Published online: April 12, 2021
      • Sofia K. Mettler
      • Jewel Park
      • Orhun Özbek
      • Linus K. Mettler
      • Po-Han Ho
      • Hye Chang Rhim
      • and others
      Cited in Scopus: 0
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        In many countries that managed to contain the earlier COVID-19 outbreaks through extensive social distancing or a large-scale lock-down, a second or third wave of the outbreak took place. Although a lock-down or strict social distancing seem to be effective in containing the epidemic, these come with very high socioeconomic costs. The contact tracing strategy of “Diagnose, Trace, Isolate” has been highlighted as a more sustainable alternative in addition to personal hygiene measures such as wearing masks and washing hands (Rajan et al., 2020; World Health Organization, 2020a).
        The importance of timely contact tracing — A simulation study
      • Review
        Open Access

        Accounting for health inequities in the design of contact tracing interventions: A rapid review

        International Journal of Infectious Diseases
        Vol. 106p65–70Published online: March 11, 2021
        • Isadora Mathevet
        • Katarina Ost
        • Lola Traverson
        • Kate Zinszer
        • Valéry Ridde
        Cited in Scopus: 7
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Contact tracing plays a key role in controlling communicable diseases by seeking to break the chain of transmission between individuals. It is recommended by the World Health Organization (WHO) as part of the global strategy for coronavirus disease 2019 (COVID-19), which also includes case identification, isolation, testing, care, and quarantine (World Health Organization, 2020). Contact tracing consists of identifying and monitoring individuals who have been in close contact with an infected person (Public Health Ontario, 2021).
          Accounting for health inequities in the design of contact tracing interventions: A rapid review
        • Short Communication
          Open Access

          Transmissibility of asymptomatic COVID-19: Data from Japanese clusters

          International Journal of Infectious Diseases
          Vol. 105p236–238Published online: February 19, 2021
          • Ko Nakajo
          • Hiroshi Nishiura
          Cited in Scopus: 16
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            The early estimate of asymptomatic ratio has been reported as ranging from 8 to 54% (Nishiura et al., 2020). Besides, more than half of secondary transmissions with coronavirus disease 2019 (COVID-19) are considered to occur from asymptomatically infected people (Johansson et al., 2021). The estimate reflects the substantial number of secondary transmissions from pre-symptomatic individuals who eventually develop illness.
            Transmissibility of asymptomatic COVID-19: Data from Japanese clusters
          • Research Article
            Open Access

            Types of COVID-19 clusters and their relationship with social distancing in the Seoul metropolitan area, South Korea

            International Journal of Infectious Diseases
            Vol. 106p363–369Published online: February 17, 2021
            • Yoon-Jung Choi
            • Mi-jeong Park
            • Soo Jin Park
            • Dongui Hong
            • Sohyae Lee
            • Kyung-Shin Lee
            • and others
            Cited in Scopus: 13
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              In the week before October 27, 2020, an exponential increase in the number of new weekly coronavirus disease-19 (COVID-19) cases was reported worldwide, with over 2.8 million new cases and approximately 40 000 deaths (WHO, 2020). As of October 27, a cumulative total of >42 million COVID-19 cases and 1.1 million deaths had been reported worldwide (WHO, 2020); among these, a total of 22 364 cases and 460 deaths were reported in South Korea (Korea Disease Control and Prevention Agency, 2020). During the initial COVID-19 epidemic phase in South Korea from February to March 2020, a massive outbreak in Daegu accounted for the majority of cases, whereas cases in the Seoul metropolitan area were not prominent, despite outbreaks at the Guro-gu customer service call center and Itaewon night clubs (Jung et al., 2020; Park et al., 2020).
              Types of COVID-19 clusters and their relationship with social distancing in the Seoul metropolitan area, South Korea
            • Research Article
              Open Access

              Impact of contact tracing, respect of isolation, and lockdown in reducing the number of cases infected with COVID-19. Case study: Tunisia’s response from March 22 to May 4, 2020

              International Journal of Infectious Diseases
              Vol. 113p26–33Published online: February 9, 2021
              • Olfa Saidi
              • Dhafer Malouche
              • Priyanka Saksena
              • Latifa Arfaoui
              • Khouloud Talmoudi
              • Aicha Hchaichi
              • and others
              Cited in Scopus: 3
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                Coronavirus disease 2019 (COVID-19) has spread rapidly across the world. Tunisia reacted early to COVID-19, resulting in a low number of infections during the first wave of the pandemic. This study was performed to model the effects of different interventions on the evolution of cases and to compare these with the Tunisian experience.
                Impact of contact tracing, respect of isolation, and lockdown in reducing the number of cases infected with COVID-19. Case study: Tunisia’s response from March 22 to May 4, 2020
              • Perspective
                Open Access

                Contact tracing with digital assistance in Taiwan’s COVID-19 outbreak response

                International Journal of Infectious Diseases
                Vol. 101p348–352Published online: October 6, 2020
                • Shu-Wan Jian
                • Hao-Yuan Cheng
                • Xiang-Ting Huang
                • Ding-Ping Liu
                Cited in Scopus: 30
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  As of September 21, 2020, over 30.6 million coronavirus disease 2019 (COVID-19) cases and 950,000 deaths have been reported globally (World Health Organization, 2020a) Case detection and contact tracing were essential components to control the spread of COVID-19. Taiwan government has enhanced notifiable disease reporting and laboratory surveillance since January 2020 by testing the respiratory specimens from various sources for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including patients who were reported as cases of severe or novel influenza infection, clusters of upper respiratory disease/fever of unknown origin, and patients with respiratory infections via the sentinel surveillance.
                  Contact tracing with digital assistance in Taiwan’s COVID-19 outbreak response
                • Research Article
                  Open Access

                  Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea

                  International Journal of Infectious Diseases
                  Vol. 99p346–351Published online: August 6, 2020
                  • Sofia K. Mettler
                  • Jihoo Kim
                  • Marloes H. Maathuis
                  Cited in Scopus: 10
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    The serial interval of an infectious disease, also known as the generation time, is defined as the time between analogous phases in successive cases of a chain of infection (Porta, 2016). The transmission interval, or the time between the infection events of the infector and the infectee, is a particularly crucial serial interval as it determines how rapidly a disease can spread in the community (Fine, 2003) and provides a time window for its containment. This interval, however, is difficult to measure, as times of infection are often unknown.
                    Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea
                  • Running heads:Recto: Epidemiology of COVID-19 in Hong Kong
                    Open Access

                    The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong–January to May 2020

                    International Journal of Infectious Diseases
                    Vol. 98p51–58Published online: June 21, 2020
                    • Ho Yeung Lam
                    • Tsz Sum Lam
                    • Chi Hong Wong
                    • Wing Hang Lam
                    • Chi Mei Emily Leung
                    • Ka Wing Albert Au
                    • and others
                    Cited in Scopus: 57
                    • Preview Hide Preview
                    • Download PDF
                    • Export Citation
                      Hong Kong Special Administrative Region, with a population of 7.4 million, is a major financial and transport hub located at the southern coast of China and has intimate ties with mainland China and the rest of the world. Having experienced the severe acute respiratory syndrome (SARS) outbreak in 2003, Hong Kong closely monitored the situation of coronavirus disease 2019 (COVID-19) following the first report in Wuhan on 31 December 2019. In early January 2020, COVID-19 was included as a statutory notifiable disease.
                      The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong–January to May 2020
                    Page 1 of 1
                    Skip menu

                      Login to your account

                      Show
                      Forgot password?
                      Don’t have an account?
                      Create a Free Account

                      If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                      If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                      Cancel
                      • Home
                      • Articles & Issues
                      • Articles In Press
                      • Current Issue
                      • List of Issues
                      • Supplements
                      • Collections
                      • IJID COVID-19
                      • Emerging Infectious Diseases in the Time of Ebola
                      • Featured Content
                      • For Authors
                      • About Open Access
                      • Author Information
                      • Permissions
                      • Researcher Academy
                      • Submit a Manuscript
                      • Journal Info
                      • About the Journal
                      • About Open Access
                      • Contact Information
                      • Editorial Board
                      • Info for Advertisers
                      • Reprints
                      • New Content Alerts
                      • News and Media
                      • ISID
                      • ProMED
                      • More Periodicals
                      • Find a Periodical
                      • Go to Product Catalog
                      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
                      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

                      • Privacy Policy  
                      • Terms and Conditions  
                      • Accessibility  
                      • Help & Contact

                      RELX